tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
US Market
IDYA
IDEAYA Biosciences
RESEARCH TOOLSreports
Advertisement

IDEAYA Biosciences (IDYA) Stock News & Sentiment

Compare
614 Followers
Promising Potential of IDEAYA Biosciences’ Darovasertib: Strong Efficacy and Safety in Uveal Melanoma Trials
Premium
Ratings
Promising Potential of IDEAYA Biosciences’ Darovasertib: Strong Efficacy and Safety in Uveal Melanoma Trials
15h ago
IDYA
IDEAYA Biosciences Presents Promising Phase 2 Data
Premium
Company Announcements
IDEAYA Biosciences Presents Promising Phase 2 Data
18h ago
8K
IDYA
IDEAYA Biosciences: Promising Phase 1/2 Trial Results and Strong Upside Potential Justify Buy Rating
Premium
Ratings
IDEAYA Biosciences: Promising Phase 1/2 Trial Results and Strong Upside Potential Justify Buy Rating
1d ago
IDYA
Promising Potential of IDEAYA Biosciences: Strong Efficacy and Financial Stability Support Buy Rating
Premium
Ratings
Promising Potential of IDEAYA Biosciences: Strong Efficacy and Financial Stability Support Buy Rating
4d ago
IDYA
IDEAYA Biosciences: Promising Outlook for Darovasertib in Uveal Melanoma Drives Buy Rating
Premium
Ratings
IDEAYA Biosciences: Promising Outlook for Darovasertib in Uveal Melanoma Drives Buy Rating
13d ago
IDYA
Ideaya Biosciences Advances IDE849 Study for DLL3-Expressing Tumors
Premium
Company Announcements
Ideaya Biosciences Advances IDE849 Study for DLL3-Expressing Tumors
25d ago
IDYA
Promising Developments in IDEAYA Biosciences’ Pipeline Drive Buy Rating with $74 Price Target by 2026
Premium
Ratings
Promising Developments in IDEAYA Biosciences’ Pipeline Drive Buy Rating with $74 Price Target by 2026
26d ago
IDYA
More IDYA News >

IDYA News on the Web

Darovasertib Phase 2 Results Show Robust Tumor Shrinkage and Vision Preservation in Uveal Melanoma
Market Chameleon
Neutral
RBC Capital Reaffirms Their Buy Rating on IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Mizuho Securities Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Why IDEAYA Biosciences, Inc.’s (IDYA) Stock Is Up 5.17%
AAII
Neutral
IDYA Grants 31,400 Stock Options at $25.69—What Does This Mean for Investors?
Market Chameleon
Neutral
JPMorgan places 'Positive Catalyst Watch' on Ideaya into updates
The Fly
Neutral
Mizuho Securities Sticks to Their Buy Rating for IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Ideaya should be bought on yesterday's selloff, says Wells Fargo
The Fly
Neutral

News Score - Last 7 Days

Neutral
IDYA
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IDYA’s Media Buzz Sentiment?
3 articles about IDYA were published this week. In an average week, 1.5 articles are published.
    What is IDYA’s weekly average amount of articles?
    In an average week, 1.5 articles about IDYA are published.
      What is IDYA’s News Sentiment?
      50% of articles about IDYA were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        IXIIXICO plc
        TDOCTeladoc
        VSTMVerastem
        ANIPANI Pharmaceuticals
        CVSCVS Health
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing